Predictive Biomarkers of Response to Nivolumab in Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study

被引：0
|
作者：
Kataoka, Y. [1 ]
Hirano, K. [1 ]
Narabayashi, T. [2 ]
Hara, S. [3 ]
Fujimoto, D. [4 ]
Tanaka, T. [5 ]
Ebi, N. [6 ]
Tomii, K. [4 ]
Yoshioka, H. [5 ]
机构：
[1] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Resp Med, Amagasaki, Hyogo, Japan
[2] Jcho Osaka Hosp, Osaka, Japan
[3] Itami City Hosp, Dept Internal Med, Itami, Hyogo, Japan
[4] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan
[5] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
[6] Iizuka Hosp, Dept Resp Med, Iizuka, Fukuoka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
immunotherapy; NSCLC; biomarker;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.07-004
引用
收藏
页码：S1995 / S1995
页数：1
相关论文
共 50 条
  • [21] Nivolumab, a new hope in non-small cell lung cancer
    Flippot, Ronan
    Fallet, Vincent
    Besse, Benjamin
    Massard, Christophe
    Wislez, Marie
    Vignot, Stephane
    BULLETIN DU CANCER, 2015, 102 (12) : 1046 - 1052
  • [22] The use of biomarkers in the treatment of non-small cell lung cancer
    Baumgart, Megan
    Pandya, Kishan
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2016, 1 (01): : 25 - 36
  • [23] Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: A multicentre retrospective study
    Ravanelli, Marco
    Agazzi, Giorgio Maria
    Milanese, Gianluca
    Roca, Elisa
    Silva, Mario
    Tiseo, Marcello
    Rondi, Paolo
    Baggi, Alice
    Ganeshan, Balaji
    Muri, Margherita
    Panni, Stefano
    Botti, Camilla
    Sverzellati, Nicola
    Maroldi, Roberto
    Berruti, Alfredo
    Farina, Davide
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 118 : 251 - 256
  • [24] Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancer
    Prelaj, Arsela
    Tay, Rebecca
    Ferrara, Roberto
    Chaput, Nathalie
    Besse, Benjamin
    Califano, Raffaele
    EUROPEAN JOURNAL OF CANCER, 2019, 106 : 144 - 159
  • [25] The Combination of Radiotherapy With Immunotherapy and Potential Predictive Biomarkers for Treatment of Non-Small Cell Lung Cancer Patients
    Meng, Lu
    Xu, Jianfang
    Ye, Ying
    Wang, Yingying
    Luo, Shilan
    Gong, Xiaomei
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [26] Exploring histological predictive biomarkers for immune checkpoint inhibitor therapy response in non-small cell lung cancer
    Cho, Uiju
    Im, Soyoung
    Park, Hyung Soon
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2024, 58 (02) : 49 - 58
  • [27] Retrospective analysis of inflammatory biomarkers and prognosis in non-small cell lung cancer without adenocarcinoma in situ
    Zhao, Qing
    Cui, Songping
    Hu, Bin
    Chen, Shuo
    FRONTIERS IN GENETICS, 2025, 16
  • [28] Biomarkers in non-small cell lung cancer prevention
    Hilbe, W
    Dirnhofer, S
    Greil, R
    Wöll, E
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2004, 13 (05) : 425 - 436
  • [29] The role of biomarkers in stage III non-small cell lung cancer
    Rosell, Rafael
    Gonzalez-Cao, Maria
    Ito, Masaoki
    Santarpia, Mariacarmela
    Aguilar, Andres
    Codony-Servat, Jordi
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2023, 17 (06) : 469 - 480
  • [30] Bone Metastases in Non-Small Cell Lung Cancer: A Retrospective Study
    Bagri, Puneet K.
    Samdariya, Saurabh
    Pareek, Puneet
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S768 - S768
12345